Senior Associate
Civilization VenturesCheck size: Civilization Ventures does not publish a standard check-size range on its official site.
Sarah Loveland invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Scientific founders addressing essential health problems with breakthrough evidence and a path to generational impact.
Companies outside human health and life sciences, or without credible scientific differentiation, are less aligned.
Show the science, validation, unmet medical need, regulatory and commercial pathway, team and the next value-inflecting experiment.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Sarah Loveland is a current Senior Associate at Civilization Ventures, according to the firm's official roster. The record preserves the official role and does not infer unsupported employment history.